Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diabetes Testing Results Remotely Managed and Monitored

By LabMedica International staff writers
Posted on 28 Sep 2011
Point-of-care (POC) coordinators and laboratory managers can remotely monitor and manage HbA1c and microalbumin testing results using expanded data management solution connectivity.

The new RAPIDComm system is accessible from any computer connected to the hospital-wide network and can be customized to address the needs of different departments, users, and patients. More...
With this system, POC coordinators are able to remotely manage and maximize instrument uptime, simplify instrument control, and operator management.

Siemens Healthcare Diagnostics (Tarrytown, NY, USA) launched the RAPIDComm new data management solution Version 4.0, extending system connectivity to the company’s DCA Vantage diabetes analyzer. The data management system also enhances quality control (QC) management and documentation with automated QC result processing and customizable regulatory reports.

Now point-of-care (POC) laboratory managers are able to rely on a single, advanced user interface to remotely monitor and manage diabetes-testing results, in addition to blood gas via RAPIDSystems, and urinalysis via the CLINITEK Status Connect System. This move further integrates patient data throughout the healthcare network.

With decentralized testing, POC coordinators may be responsible for monitoring large numbers of instruments spread throughout a hospital or various hospital sites, which are operated by several hundred to several thousand operators.

“Healthcare professionals that manage POC testing in hospitals, clinics, and physician offices are increasingly looking to integrate their instruments with a data management solution to reduce transcription errors and better manage data, quality control, and operators, which ultimately helps to improve patient care,” said David Stein, PhD, CEO, Point of Care Business Unit, Siemens Healthcare Diagnostics. “A key priority for Siemens is to continue the innovation of our instruments and data management solutions to provide our POC customers with innovative and flexible connectivity options.”

Related Links:
Siemens Healthcare Diagnostics



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.